טוען...
Monosialotetrahexosy-1 ganglioside attenuates diabetes-enhanced brain damage after transient forebrain ischemia and suppresses phosphorylation of ERK1/2 in the rat brain
Monosialotetrahexosy-1 ganglioside (GM1) has been shown to reduce brain damage induced by cerebral ischemia. The objective of this study is to determine whether GM1 is able to ameliorate hyperglycemia-exacerbated ischemic brain damage in hyperglycemia-recruited areas such as the hippocampal CA3 sub...
שמור ב:
Main Authors: | , , , , , |
---|---|
פורמט: | Artigo |
שפה: | Inglês |
יצא לאור: |
2010
|
נושאים: | |
גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2900456/ https://ncbi.nlm.nih.gov/pubmed/20546707 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.brainres.2010.05.044 |
תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|